These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6324038)

  • 1. [Humoral mechanisms in neoplastic hypercalcemia].
    Gennari C; Montagnani M; Nami R; Francini G
    Minerva Med; 1984 Feb; 75(6):235-9. PubMed ID: 6324038
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors.
    Seyberth HW; Segre GV; Hamet P; Sweetman BJ; Potts JT; Oates JA
    Trans Assoc Am Physicians; 1976; 89():92-104. PubMed ID: 190750
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium and the nervous system.
    O'Riordan JL
    Proc R Soc Med; 1972 Oct; 65(10):873-4. PubMed ID: 4343593
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercalcaemia. Management.
    Selby PC; Peacock M; Marshall DH
    Br J Hosp Med; 1984 Mar; 31(3):186, 188, 190 passim. PubMed ID: 6324944
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
    Gottleib S; Rude RK; Sharp CF; Singer FR
    Am J Med; 1982 Nov; 73(5):751-5. PubMed ID: 6291389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations.
    Meuten DJ; Kociba GJ; Capen CC; Chew DJ; Segre GV; Levine L; Tashjian AH; Voelkel EF; Nagode LA
    Lab Invest; 1983 Nov; 49(5):553-62. PubMed ID: 6314038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.
    Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA
    N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary cyclic AMP as an aid in the differential diagnosis of hypercalcemia.
    Debacker M; Manderlier T; Nijs-Dewolf N; Six R; Corvilain J
    Biomedicine; 1974 Aug; 21(8):338-41. PubMed ID: 4374265
    [No Abstract]   [Full Text] [Related]  

  • 9. Exocrine pancreatic cancer with humoral hypercalcemia.
    Monno S; Nagata A; Homma T; Oguchi H; Kawa S; Kaji R; Furuta S
    Am J Gastroenterol; 1984 Feb; 79(2):128-32. PubMed ID: 6695885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral nonparathyroid hypercalcemia without evidence of bone involvement.
    Liberati AM; Di Costanzo F; Anasetti C; Buzzi F; Falchi R; Grignani F
    Tumori; 1983 Jun; 69(3):223-6. PubMed ID: 6306887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
    Robertson RP; Baylink DJ; Metz SA; Cummings KB
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man.
    Berger ME; Golub MS; Sowers JR; Brickman AS; Nyby M; Troyer H; Rude RK; Singer FR; Horst R; Deftos LJ
    Life Sci; 1982 May; 30(18):1509-15. PubMed ID: 6281603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous parathyroid and pharyngeal tumors with normal PTH and NcAMP.
    Baldwin DB; Rowett DA
    Conn Med; 1980 Sep; 44(9):541-4. PubMed ID: 6250765
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated prostaglandin and indomethacin-responsive hypercalcemia in a patient with malignant pheochromocytoma.
    Uchida T; Kuwao S; Ishibashi A; Koshiba K
    J Urol; 1985 Oct; 134(4):712-3. PubMed ID: 4032577
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Prostaglandins, indomethacin and hypercalcemia in neoplastic disease.
    Benvenisti D; Goldberg H
    N Engl J Med; 1975 May; 292(22):1189-90. PubMed ID: 123636
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy.
    Brenner DE; Harvey HA; Lipton A; Demers L
    Cancer; 1982 Feb; 49(3):556-61. PubMed ID: 7059914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma.
    Robertson RP; Baylink DJ; Marini BJ; Adkison HW
    J Clin Endocrinol Metab; 1975 Jul; 41(1):164-7. PubMed ID: 1150858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infantile hypercalcemia with subcutaneous fat necrosis: endocrine studies.
    Veldhuis JD; Kulin HE; Demers LM; Lambert PW
    J Pediatr; 1979 Sep; 95(3):460-2. PubMed ID: 224162
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypercalcemia in large cell lymphoma. Possible role of prostaglandins E2 (author's transl)].
    Boissonnas A; Khalifa P; Sereni D; Mathiot C; Vacher-Lavenu MC; Hornych A; Cremer GA; Laroche C
    Ann Med Interne (Paris); 1982; 133(3):186-91. PubMed ID: 6954869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.